Boehringer Ingelheim Teams Up with the Lebanese Pulmonary Society (LPS) in its Fight against COVID-19
Boehringer Ingelheim Teams Up with the Lebanese Pulmonary Society (LPS) in its Fight against COVID-19
Search
Boehringer Ingelheim awarded Top Employer across 29 countries including the UAE, KSA and India
• The Top Employers Institute highlighted Boehringer Ingelheim’s emphasis on wellbeing, attractive work environment, and rewards and recognition when compared with the industry benchmark
Boehringer Ingelheim Ranks First Place in ‘Best Place to Work in Africa' Recognition
Boehringer Ingelheim Ranks First Place in ‘Best Place to Work in Africa' Recognition
Boehringer Ingelheim Convenes Educational Meetings to Empower Over 300 Regional Experts with Latest Heart Failure Advances
• Boehringer Ingelheim hosted ‘Heart Talks’and ‘MEDEX’ to discuss latest updates in heart failure management and help improve patient outcomes across India, the Middle East and Africa
View from Both Sides of the Table
Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships
Human Health
Human Health
Equestrian sports technology
Learn about new trends in equine health and get insights into the human-horse relationship!
Vaccines
Vaccines
Horses
Horses
Boehringer Ingelheim launches the First Approved Treatment for Idiopathic Pulmonary Fibrosis in Algeria
Nintedanib is the only treatment for Idiopathic Pulmonary Fibrosis approved by the Algerian Ministry of Health
Leading Science in Oncology
As the oncology community learns more about the complexity of tumor biology, we are discovering new and exciting therapeutic opportunities.
Boehringer Ingelheim Raises Ranking by Two Positions in Access-To-Medicine Index for 2021
Boehringer Ingelheim Raises Ranking by Two Positions in Access-To-Medicine Index for 2021
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
Board of Managing Directors
Board of Managing Directors Boehringer Ingelheim
Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease
Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease Patients Around the World
Sustainable Development - Our Commitment
Our Commitment
Boehringer Ingelheim Empowers 380 Regional Experts with Latest Insights in Cardio-Renal-Metabolic Care
Boehringer Ingelheim hosted the ‘CRM 360 standalone meeting’, ‘IMETA CRM Discussions for EXperts (MEDEX)’, to discuss the latest advances in the management of cardio-renal-metabolic conditions
Boehringer launches the Treatment for Three Interstitial Lung Diseases in Qatar
• This is the first time that an approved antifibrotic medication will be available for ILD patients residing in Qatar
German Ambassador inaugurates Boehringer Ingelheim new Cairo office
German Ambassador inaugurates Boehringer Ingelheim new Cairo office
Winners of 2020 BVDzero Case Awards announced
Winners of 2020 BVDzero Case Awards announced
Contact us
Find all our contact information here about our BD&L team.
Elevating Cardio-Renal-Metabolic Care: Boehringer Ingelheim Imparts Latest Insights to 400 Regional Experts
Boehringer Ingelheim hosted the ‘CRM Summit’ to facilitate exchanges and discussions on the latest advances in the management of cardiovascular, renal, and metabolic diseases to help improve patient outcomes across India, the Middle East and Africa
EFPIA disclosure
.
“LastMile” – improving through digital
“LastMile” – improving through digital
Pets
Pets